Exact Mass: 305.116421
Exact Mass Matches: 305.116421
Found 500 metabolites which its exact mass value is equals to given mass value 305.116421,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Convicine
Convicine is a glycoside. Convicine is a natural product found in Vicia faba and Vicia narbonensis with data available.
Pirimiphos-methyl
C11H20N3O3PS (305.09629400000006)
CONFIDENCE standard compound; INTERNAL_ID 4028 CONFIDENCE standard compound; INTERNAL_ID 2575 CONFIDENCE standard compound; INTERNAL_ID 8410 D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Imazamox
2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.
BUPROFEZIN
C16H23N3OS (305.15617480000003)
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10057; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10113; ORIGINAL_PRECURSOR_SCAN_NO 10111 ORIGINAL_ACQUISITION_NO 10127; CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10127; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10097; ORIGINAL_PRECURSOR_SCAN_NO 10096 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10129; ORIGINAL_PRECURSOR_SCAN_NO 10128
Sertraline
Sertraline is a selective serotonin uptake inhibitor that is used in the treatment of depression. Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day. Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder. A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. A selective serotonin uptake inhibitor that is used in the treatment of depression.; Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991.; Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day.; Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder.; A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. [HMDB] N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent CONFIDENCE standard compound; INTERNAL_ID 8627 CONFIDENCE standard compound; INTERNAL_ID 1500 D049990 - Membrane Transport Modulators
Zaleplon
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Cetraxate
A cyclohexanecarboxylate ester that consists of 4-(2-carboxyethyl)phenyl cyclohexanecarboxylate bearing an aminomethyl substituent at the 4-position. C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
Fenoldopam
Fenoldopam is only found in individuals that have used or taken this drug. It is a dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation. [PubChem]Fenoldopam is a rapid-acting vasodilator. It is an agonist for D1-like dopamine receptors and binds with moderate affinity to α2-adrenoceptors. It has no significant affinity for D2-like receptors, α1 and β-adrenoceptors, 5HT1 and 5HT2 receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D1-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D2-like dopamine receptors, or α or β -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration. C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Convolamine
Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids
Entacapone
Entacapone is an inhibitor drug of catechol O-methyltransferase, which catalyzes the reaction between catechol and S-adenosyl-L-methionine to produce guaiacol and S-adenosyl-L-homocysteine. [HMDB] Entacapone is an inhibitor drug of catechol O-methyltransferase, which catalyzes the reaction between catechol and S-adenosyl-L-methionine to produce guaiacol and S-adenosyl-L-homocysteine. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
4-Oxolividamine
C12H23N3O6 (305.15867779999996)
An aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-2,3-dideoxy-alpha-D-erythro-hexopyranosid-4-ulose derivative.
anisodamine
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].
Ascorbigen
Ascorbigen (CAS: 8075-98-7) belongs to the class of organic compounds known as isosorbides. These are organic polycyclic compounds containing an isosorbide (1,4-dianhydrosorbitol) moiety, which consists of two -oxolan-3-ol rings. Ascorbigen is possibly neutral. Ascorbigen is found, on average, in the highest concentration within guava and mung beans. Ascorbigen has also been detected, but not quantified, in bitter gourds and brassicas. Ascorbigen is present in plants, especially cabbage and other cruciferous plants. This could make ascorbigen a potential biomarker for the consumption of these foods. Present in plants, especies cabbage and other crucifers. Ascorbigen is found in many foods, some of which are mung bean, guava, brassicas, and bitter gourd.
N-Acetyldehydroanonaine
N-Acetyldehydroanonaine is found in fruits. N-Acetyldehydroanonaine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). N-Acetyldehydroanonaine is found in herbs and spices and fruits.
Zanthodioline
Zanthodioline is found in fruits. Zanthodioline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper
Benzosimuline
C20H19NO2 (305.14157140000003)
Benzosimuline is found in fruits. Benzosimuline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper
Syndesine
C12H23N3O6 (305.15867779999996)
Syndesine is found in animal foods. Syndesine is an intramolecular crosslink of collagen. An intramolecular crosslink of collagen. Syndesine is found in animal foods.
Threonyltryptophan
Threonyltryptophan is a dipeptide composed of threonine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Methionyl-Arginine
C11H23N5O3S (305.15215280000007)
Methionyl-Arginine is a dipeptide composed of methionine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tryptophyl-Threonine
Tryptophyl-Threonine is a dipeptide composed of tryptophan and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Arginylmethionine
C11H23N5O3S (305.15215280000007)
Arginylmethionine is a dipeptide composed of arginine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine
(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an (2S,3R)-3-hydroxy-2-methylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Hydroxyhexanedioylcarnitine
3-hydroxyhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
2-Ethyl-2-hydroxybutanedioylcarnitine
2-Ethyl-2-hydroxybutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethyl-2-hydroxybutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethyl-2-hydroxybutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethyl-2-hydroxybutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
1-(1-Naphthylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol
C20H19NO2 (305.14157140000003)
6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate
2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol
Applaud
C16H23N3OS (305.15617480000003)
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Ciprofloxacin-7-ethylenediamine
C15H16FN3O3 (305.11756379999997)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
Convicine
6-Fluoro-1-methyl-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid
C15H16FN3O3 (305.11756379999997)
m-Hydroxybenzoylecgonine
p-hydroxybenzoylecgonine
Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
7-(Diethylphosphinoyloxy)-3-cyano-4-methylcoumarin
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
1-(Naphthalen-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol
C20H19NO2 (305.14157140000003)
Sealdin
C17H17Cl2N (305.07379820000006)
6-[5-(4-Carbamimidoylphenyl)-2-furyl]pyridine-3-carboxamidine
indole-3-acetyl-methionine
C15H17N2O3S- (305.09598320000003)
Indole-3-acetyl-methionine is also known as iaa-met. Indole-3-acetyl-methionine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-methionine can be found in a number of food items such as arctic blackberry, garlic, wax gourd, and chicory roots, which makes indole-3-acetyl-methionine a potential biomarker for the consumption of these food products.
Anisodamine
6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate is a natural product found in Hyoscyamus niger with data available. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Anisodamine has been investigated for the treatment of Intestinal Diseases. 6-Hydroxyhyoscyamine is a natural product found in Duboisia myoporoides, Anisodus tanguticus, and Hyoscyamus albus with data available. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].
Rohitukine
A member of the class of chromones that is 4H-chromen-4-one in which the hydrogens at positions 2,5,7 and 8 are replaced by methyl, hydroxy, hydroxy, and (3S,4R)-3-hydroxy-1-methylpiperidin-4-yl groups, respectively. It is an alkaloid initially isolated from Amoora rohituka and is a precursor of the anti-cancer compound flavopiridol.
N-Acetyldehydroanonaine
(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt
dimethyl 2,6-dimethyl-4-(2-thienyl)pyridine-3,5-dicarboxylate
1-(1-isoquinolyl)-2-methylpropyl benzoate
C20H19NO2 (305.14157140000003)
18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien
1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one
(E)-4-Methoxy-2-(3,4-methylenedioxystyryl)quinoline|2-(3,4-methylenedioxystyryl)-4-methoxyquinoline
2-(3,4-dihydro-2-hydroxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine A
C17H11N3O3 (305.08003759999997)
(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide
8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline
2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione
Imazamox
2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.
Entacapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
fenoldopam
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Sertraline
C17H17Cl2N (305.07379820000006)
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
Zaleplon
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
1H-1,2,4-Triazole-1-propanoic acid, 3-ethyl-4,5-dihydro-5-oxo-4-(2-phenoxyethyl)-
Desethyleneciprofloxacin
C15H16FN3O3 (305.11756379999997)
Arg-met
C11H23N5O3S (305.15215280000007)
A dipeptide formed from L-arginine and L-methionine residues.
Met-arg
C11H23N5O3S (305.15215280000007)
A dipeptide formed from L-methionine and L-arginine residues.
THR-TRP
A dipeptide composed of L-threonine and L-tryptophan joined by a peptide linkage.
Ascorbigen
An indolyl carbohydrate that consists of (3aS,6S,6aR)-3,3a,6-trihydroxy-3-tetrahydrofuro[3,2-b]furan-2-one in which position 3 is substituted by an indol-3-ylmethyl group. Formed from indole-3-carbinol and ascorbic acid in brassica vegetables.
benzosimuline
C20H19NO2 (305.14157140000003)
Syndesine
C12H23N3O6 (305.15867779999996)
2-amino-4-(furan-2-yl)-3-nitro-6-phenylbenzonitrile
C17H11N3O3 (305.08003759999997)
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)
2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide
tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate
Toluidine Blue
D006401 - Hematologic Agents > D003029 - Coagulants > D006494 - Heparin Antagonists D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D004396 - Coloring Agents
cis-entacapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors
1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one
3-Methyl-2-(4-propylphenyl)quinoline-4-carboxylic acid
C20H19NO2 (305.14157140000003)
azure b
An organic chloride salt having 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ium as the counterion. It is used in making azure eosin stains for blood smear staining and is an active metabolite of methylene blue. D004396 - Coloring Agents > D001399 - Azure Stains
3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE
2-amino-6-(furan-2-yl)-3-nitro-4-phenylbenzonitrile
C17H11N3O3 (305.08003759999997)
(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID
C15H20BNO5 (305.14344600000004)
4-(ETHYLCARBAMOYL)-3,6-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate
(2-(N-Benzylsulfamoyl)-5-methylphenyl)boronic acid
C14H16BNO4S (305.08930460000005)
Orphenadrine hydrochloride
N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AB - Ethers chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
ethyl 2-methyl-4,5-diphenyl-1H-pyrrole-3-carboxylate
C20H19NO2 (305.14157140000003)
Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)
2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOIC ACID
3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione
C16H23N3OS (305.15617480000003)
(S)-(-)-N-(3-PENTYL)-1-PHENYLETHYLAMINEHYDROCHLORIDE
1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride
C14H13ClFN5 (305.08434600000004)
4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile
2-tert-Butyl-1-methyl-4-(trimethylstannyl)-1H-imidazole
6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine
C14H19N5O3 (305.14878239999996)
2-[[(4-Methylphenyl)sulfonyl]amino]benzoic acid methyl ester
[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid
C15H20BNO5 (305.14344600000004)
2-borono-1-[(2-methylpropan-2-yl)oxycarbonyl]indole-5-carboxylic acid
(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone
ethyl 2-methyl-1,5-diphenylpyrrole-3-carboxylate
C20H19NO2 (305.14157140000003)
5-(N-BENZYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID
C14H16BNO4S (305.08930460000005)
5-(4-chlorophenyl)-9-methyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine
2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride
2-amino-1-(4-benzylpiperazin-1-yl)ethanone,dihydrochloride
benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate
Methyl 4-amino-3-fluoro-5-nitro-2-(phenylamino)benzoate
Nicofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent
N-BENZYL-2-PIPERAZIN-1-YL-ACETAMIDE DIHYDROCHLORIDE
1-[2-[(2-HYDROXYETHYL)THIO]ETHYL]-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID
Ethyl 5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate
tert-butyl 3-(3-bromopropyl)piperidine-1-carboxylate
tert-Butyl 4-(3-bromopropyl)piperidine-1-carboxylate
Dribendazole
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
[4-(2,4-difluorophenyl)-2-(methylcarbamoyl)phenyl] acetate
Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate
VU 0357121
VU 0357121 is a positive and highly selective mGlu5R allosteric modulator (PAM) with an EC50 of 33 nM. VU 0357121 is inactive or very weakly antagonizing at other mGlu receptor subtypes[1].
2-(4-TERT-BUTYLPHENYL)QUINOLINE-4-CARBOXYLICACID
C20H19NO2 (305.14157140000003)
Tenofovir Monohydrate
C9H16N5O5P (305.08890160000004)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
7-Benzyl-4-chloro-2-(methylthio)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine
N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride
Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester
Benzoic acid, 4-[(6-deoxy-α-L-mannopyranosyl)amino]-, sodium salt
N-(1-(2-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide
N-(1-(3-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide
7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester
6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline
C17H20ClNO2 (305.11824900000005)
1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride
C11H26Cl3N3 (305.11922060000006)
(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid
C15H20BNO5 (305.14344600000004)
Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate
2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL
2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
C15H20BNO5 (305.14344600000004)
N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide
1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride
C14H25Cl2N3 (305.14254300000005)
1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate
1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate
3-(5-ethyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
2-Quinolinecarboxylic acid (1-oxo-1-phenylpropan-2-yl) ester
1-methyl-5-[(4-methylphenyl)sulfanyl]-3-phenyl-1H-pyrazole-4-carbonitrile
C18H15N3S (305.09866300000004)
1-(2-Fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea
2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid
N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide
1-(2-Furyl)-3-[(2-phenoxyphenyl)amino]-2-propen-1-one
N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine
(1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
C17H17Cl2N (305.07379820000006)
9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid
C20H19NO2 (305.14157140000003)
1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium
6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one
3-(4-Fluorophenyl)-1-hydroxy-2-(pyridin-4-YL)-1H-pyrrolo[3,2-B]pyridine
N-(8,9,10-Trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-YL-acetamide
[(4Z)-2-(1-Amino-2-hydroxyethyl)-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-YL]acetic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione
Disipal
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
Alnert
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea
2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid
7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile
1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea
C16H23N3OS (305.15617480000003)
N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide
N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine
N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide
5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline
N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide
C16H23N3OS (305.15617480000003)
5-[(2-Methyl-5-nitroanilino)methyl]-2-(methylthio)-4-pyrimidinamine
2-hydroxy-N-[(2E)-1-(5-nitro-2H-tetrazol-2-yl)propan-2-ylidene]benzohydrazide
3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione
Thr-Ala-Asp
A tripeptide composed of L-threonine, L-alanine, and L-aspartic acid joined by peptide linkages.
N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide
N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide
N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine
N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid
4-(2,3-Dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one
C20H19NO2 (305.14157140000003)
N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide
1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione
N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide
(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine
2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one
2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid
N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide
N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide
C16H23N3OS (305.15617480000003)
N-methyl-N-[5-(5-methyl-2-pyrazinyl)-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide
N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide
2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide
2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
N-acetyl-L-methionyl-L-asparagine
C11H19N3O5S (305.10453640000003)
1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid
3-[3-Ethyl-5-oxo-4-(2-phenoxyethyl)-1,2,4-triazol-1-yl]propanoic acid
(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate
C14H25O7- (305.16002000000003)
(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate
C14H25O7- (305.16002000000003)
Pirimiphos-methyl
C11H20N3O3PS (305.09629400000006)
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
FPTQ
FPTQ is potent mGluR1 antagonist with IC50 values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively[1]. FPTQ has anti-oxidant and anti-inflammatory effects in vitro and in vivo[2].
GN44028
GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers[1][3].
N-Propargyladenosine
C13H15N5O4 (305.11239900000004)
N-Propargyladenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. N-Propargyladenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
1-{5-hydroxy-2,8-dimethylphenanthro[3,4-d][1,3]oxazol-4-yl}ethanone
(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one
(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate
6,6,9,12-tetramethylisochromeno[4,3-c]quinolin-11-one
C20H19NO2 (305.14157140000003)
(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid
1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde
2-[(4-amino-2,6-dihydroxypyrimidin-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol
methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate
2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid
(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt
{"Ingredient_id": "HBIN006744","Ingredient_name": "(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt","Alias": "NA","Ingredient_formula": "C16H19NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}